Zelekha to present credit reform

A second reform would initiate trade in government bonds by primary dealers (major market makers), including foreign banks, to bring down government fund raising costs.

By DANIEL KENNEMER
May 24, 2006 06:42

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Accountant-General Yaron Zelekha is preparing to present "far-reaching" reforms for the credit market promoted by his office during the Finance Banking and Insurance Exhibit set to take place in Tel Aviv on May 29 (FBIE 2006), conference organizers said Tuesday. One reform would introduce repurchasing agreement ("repo") law to Israel, creating channels to receive credit independent of the banks, "opening the credit market to real competition," the organizers said. A second reform would initiate trade in government bonds by primary dealers (major market makers), including foreign banks, to bring down government fund raising costs.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS